In patients with NAFLD, insulin-like growth factor-1(IGF-1) levels are low, reducing anti-estrogen resistance resulting from activation of Akt and mitogen-activated protein kinase (MAPK) signaling networks [34]. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.